In advanced‐stage high‐grade serous ovarian cancer, TGF‐β signaling is upregulated and is accompanied by global repression of miRNA expression, as observed through transcriptomic and miRNA expression analyses of patient tumor samples. The gene discussed is TGFB1; the disease is neoplasm.